Insider · CIK 0001786335
Howard Horn
Files at RARE (Ultragenyx Pharmaceutical Inc.). First filing Oct 11, 2024, latest Mar 10, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RARE: Ultragenyx Pharmaceutical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Ultragenyx Pharmaceutical Inc. | $72k 1,785 shares | -2% | - | |
| 38Weak | RAREsell Ultragenyx Pharmaceutical Inc. | $394k 7,465 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock | -1,785 | $40.40 | $72k | 106,169 | Mar 10, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock | +15,653 | $0.00 | $0 | 107,954 | Mar 4, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Stock Option (Right to Buy)derivative | +28,160 | $0.00 | $0 | 28,160 | Mar 4, 2025 |
| Oct 10, 2024 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock | -7,465 | $52.76 | $394k | 92,301 | Oct 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.